Western Wealth Management »

Immunitybio shares owned by Western Wealth Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Western Wealth Management from 13F filings

Historical chart of Western Wealth Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Western Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Western Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $103k 21k 5.02
2023-09-30 $35k 21k 1.69
2023-06-30 $58k 21k 2.78

More positions owned by Western Wealth Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Amazon (AMZN)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Specialized Funds Div App Etf (VIG)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Ishares Tr S&p 500 Grwt Etf (IVW)
First Tr Exchange-traded Cap Strength Etf (FTCS)

View all positions for Western Wealth Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Geode Capital Management
Susquehanna International
Credit Suisse
Jpmorgan Chase & Co
Northern Trust
Rafferty Asset Management
Bank of America Corporation
Goldman Sachs Group
Charles Schwab Investment Management
Citigroup
Perceptive Advisors
Citadel Advisors
Sheets Smith Wealth Management

View all funds holding Immunitybio